Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$673,100
$106.72 P/Share
|
|
Jul 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Jul 01
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Jul 01
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.67%
|
$3,385,200
$104.61 P/Share
|
|
Jul 01
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Jul 01
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Jun 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.09%
|
$641,350
$101.0 P/Share
|
|
Jun 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.74%
|
$133,350
$21.76 P/Share
|
|
Jun 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,410
-10.96%
|
$344,410
$101.17 P/Share
|
|
Jun 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,410
+9.88%
|
$75,020
$22.29 P/Share
|
|
Jun 14
2021
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
24,000
-60.26%
|
$2,376,000
$99.96 P/Share
|
|
Jun 14
2021
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+37.6%
|
$1,080,000
$45.28 P/Share
|
|
Jun 14
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-16.39%
|
$1,093,950
$99.84 P/Share
|
|
Jun 14
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Jun 14
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$775,170
$99.91 P/Share
|
|
Jun 14
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Jun 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Jun 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-14.76%
|
$3,157,350
$97.23 P/Share
|
|
Jun 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Jun 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
May 28
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
2,061
-6.92%
|
$195,795
$95.29 P/Share
|
|
May 25
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
4,665
-13.55%
|
$447,840
$96.09 P/Share
|
|
May 24
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
33,000
-7.65%
|
$3,135,000
$95.84 P/Share
|
|
May 24
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,000
+12.99%
|
$693,000
$21.76 P/Share
|
|
May 17
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69,562
+27.01%
|
-
|
|
May 17
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,510
-7.37%
|
$846,390
$89.49 P/Share
|
|
May 17
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
15,750
+19.29%
|
-
|
|
May 17
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,168
-11.07%
|
$904,952
$89.49 P/Share
|
|
May 17
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,193
+26.66%
|
-
|
|
May 17
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
5,233
-2.56%
|
$465,737
$89.49 P/Share
|
|
May 17
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
8,662
+7.75%
|
-
|
|
May 17
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-1.9%
|
$18,156
$89.49 P/Share
|
|
May 17
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
9,278
-10.97%
|
$825,742
$89.49 P/Share
|
|
May 17
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
15,225
+25.83%
|
-
|
|
May 17
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
9,907
-1.3%
|
$881,723
$89.49 P/Share
|
|
May 17
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
16,406
+4.12%
|
-
|
|
May 17
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-0.25%
|
$68,174
$89.49 P/Share
|
|
May 17
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,631
+6.5%
|
-
|
|
May 17
2021
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-6.75%
|
$101,994
$89.49 P/Share
|
|
May 11
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,570
-4.96%
|
$141,300
$90.4 P/Share
|
|
May 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-1.14%
|
$98,100
$90.4 P/Share
|
|
May 11
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,106
-4.03%
|
$189,540
$90.4 P/Share
|
|
May 11
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-2.48%
|
$24,660
$90.4 P/Share
|
|
May 11
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
2,028
-6.65%
|
$182,520
$90.4 P/Share
|
|
May 11
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
2,106
-0.57%
|
$189,540
$90.4 P/Share
|
|
May 11
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-0.1%
|
$12,870
$90.4 P/Share
|
|
May 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.09%
|
$720,360
$92.22 P/Share
|
|
May 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.04%
|
$274,050
$35.2 P/Share
|
|
May 07
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-0.18%
|
$61,789
$91.75 P/Share
|
|
May 07
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-0.04%
|
$4,641
$91.75 P/Share
|